Zurich Cantonal Bank
RYTM icon

Zurich Cantonal Bank’s Rhythm Pharmaceuticals RYTM Stock Holding History

Zurich Cantonal Bank’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.57M Buy
23,109
+7,511
+48% +$679K ﹤0.01% 993
2026
Q1 		$1.36M Buy
+15,598
New +$1.52M ﹤0.01% 1255
2025
Q4 		– Sell
-10,726
Closed -$1.14M – 3351
2025
Q3 		$1.08M Buy
10,726
+1,074
+11% +$99.7K ﹤0.01% 1243
2025
Q2 		$610K Buy
9,652
+726
+8% +$44.5K ﹤0.01% 1532
2025
Q1 		$473K Sell
8,926
-108
-1% -$5.99K ﹤0.01% 1633
2024
Q4 		$506K Sell
9,034
-67
-0.7% -$3.7K ﹤0.01% 1619
2024
Q3 		$477K Sell
9,101
-8
-0.1% -$383 ﹤0.01% 1595
2024
Q2 		$374K Sell
9,109
-9
-0.1% -$359 ﹤0.01% 1688
2024
Q1 		$395K Sell
9,118
-63
-0.7% -$2.76K ﹤0.01% 1629
2023
Q4 		$422K Buy
9,181
+406
+5% +$12.8K ﹤0.01% 1616
2023
Q3 		$201K Sell
8,775
-174
-2% -$3.9K ﹤0.01% 1971
2023
Q2 		$148K Sell
8,949
-159
-2% -$2.87K ﹤0.01% 2118
2023
Q1 		$162K Buy
9,108
+2,229
+32% +$56K ﹤0.01% 2011
2022
Q4 		$200K Buy
6,879
+691
+11% +$17.8K ﹤0.01% 1818
2022
Q3 		$152K Buy
6,188
+2,446
+65% +$45.5K ﹤0.01% 1933
2022
Q2 		$16K Hold
3,742
– – ﹤0.01% 2820
2022
Q1 		$43K Sell
3,742
-1,656
-31% -$14.5K ﹤0.01% 2557
2021
Q4 		$54K Sell
5,398
-173
-3% -$1.94K ﹤0.01% 2712
2021
Q3 		$73K Hold
5,571
– – ﹤0.01% 2488
2021
Q2 		$109K Buy
5,571
+69
+1% +$1.43K ﹤0.01% 2177
2021
Q1 		$117K Buy
5,502
+1,760
+47% +$51K ﹤0.01% 2072
2020
Q4 		$111K Hold
3,742
– – ﹤0.01% 2169
2020
Q3 		$81K Hold
3,742
– – ﹤0.01% 2074
2020
Q2 		$83K Buy
3,742
+1,556
+71% +$30.3K ﹤0.01% 2032
2020
Q1 		$33K Hold
2,186
– – ﹤0.01% 2141
2019
Q4 		$50K Buy
+2,186
New +$48.6K ﹤0.01% 2153

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Zurich Cantonal Bank's RYTM Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Rhythm Pharmaceuticals (RYTM) stake by 48% in Q2 2026, buying an estimated $679K and bringing the position to 23,109 shares worth $2.57M. The position accounts for ﹤0.01% of the portfolio, ranked #993.

Zurich Cantonal Bank first reported a position in RYTM in Q4 2019 and has held it in 26 quarters since. 302 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Zurich Cantonal Bank held 23,109 shares of Rhythm Pharmaceuticals worth $2.57M as of Q2 2026.
  • Zurich Cantonal Bank bought 7,511 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $679K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #993 holding.
  • Zurich Cantonal Bank first reported a position in Rhythm Pharmaceuticals in Q4 2019 and has held it in 26 quarters since.
  • 302 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.